Cleared Traditional

K182245 - EV1000 Clinical Platform Non-Invasive (...

K182245 is an FDA 510(k) clearance for EV1000 Clinical Platform Non-Invasive (..., manufactured by Edwards Lifesciences, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 102-day FDA review.

K182245 · Edwards Lifesciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
102d
Days
Class 2
Risk

K182245 is an FDA 510(k) clearance for the EV1000 Clinical Platform Non-Invasive (NI) with ClearSight Finger Cuffs or Cl.... Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on November 30, 2018 after a review of 102 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

FDA 510(k) Submission Details - K182245

510(k) Number K182245 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2018
Decision Date November 30, 2018
Days to Decision 102 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 125d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K182245.
GMC Wrist Automatic Blood Pressure Monitor
K181930 · Gmc, Inc. · Feb 2019
FORA P100 Blood Pressure Monitoring System
K182934 · Taidoc Technology Corporation · Feb 2019
Arm Blood Pressure Monitor
K180435 · Alicn Medical (Shenzhen), Inc. · Jan 2019
HEM-6410T-ZM Wrist Blood Pressure Monitor
K182481 · Omron Healthcare, Inc. · Nov 2018
Wrist Blood Pressure Monitor Model BP4350
K182166 · Omron Healthcare, Inc. · Nov 2018
Finapres Nova Noninvasive Hemodynamic Monitor
K173916 · Finapres Medical Systems B.V. · Nov 2018